TY - JOUR
T1 - Atherosclerosis and restenosis
T2 - Is there a role for RAGE?
AU - Nawroth, Peter
AU - Bierhaus, Angelika
AU - Marrero, Mario
AU - Yamamoto, Hiroshi
AU - Stern, David M.
PY - 2005/2
Y1 - 2005/2
N2 - Diabetic vascular complications are a major cause of morbidity and mortality. Furthermore, such vascular disease is only incompletely explained by "traditional" risk factors in the nondiabetic complications. This situation has prompted the search for factors contributing to the pathogenesis of accelerated and more severe vascular disease in patients with diabetes. We review evidence that receptor for advanced glycation end products (RAGE), via its interaction with ligands, serves as a cofactor exacerbating diabetic vascular disease. RAGE is a member of the immunoglobulin superfamily of cell surface molecules with a diverse repertoire of ligands reminiscent of pattern recognition receptors. In the diabetic milieu, two classes of RAGE ligands, products of nonenzymatic glycoxidation and S100 proteins, appear to drive receptor-mediated cellular activation and, potentially, acceleration of vascular disease.
AB - Diabetic vascular complications are a major cause of morbidity and mortality. Furthermore, such vascular disease is only incompletely explained by "traditional" risk factors in the nondiabetic complications. This situation has prompted the search for factors contributing to the pathogenesis of accelerated and more severe vascular disease in patients with diabetes. We review evidence that receptor for advanced glycation end products (RAGE), via its interaction with ligands, serves as a cofactor exacerbating diabetic vascular disease. RAGE is a member of the immunoglobulin superfamily of cell surface molecules with a diverse repertoire of ligands reminiscent of pattern recognition receptors. In the diabetic milieu, two classes of RAGE ligands, products of nonenzymatic glycoxidation and S100 proteins, appear to drive receptor-mediated cellular activation and, potentially, acceleration of vascular disease.
UR - http://www.scopus.com/inward/record.url?scp=14044268796&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=14044268796&partnerID=8YFLogxK
U2 - 10.1007/s11892-005-0061-9
DO - 10.1007/s11892-005-0061-9
M3 - Review article
C2 - 15663911
AN - SCOPUS:14044268796
SN - 1534-4827
VL - 5
SP - 11
EP - 16
JO - Current Diabetes Reports
JF - Current Diabetes Reports
IS - 1
ER -